Founded 2019
Founders Dora Sabino, CEO, Blazar Renan Pereira, CTO, Blazar

Blazar uses machine learning to predict cancer response to immunotherapy.

Immunotherapies are a groundbreaking cancer treatment curing patients with a success impossible five years ago. Unfortunately they work in only 20% of patients, may cause several adverse effects and are very costly to develop.

At Blazar we apply machine learning to patient data providing predictions and insights on treatment response. This allows for better patient recruitment for clinical trials and better understanding on failure reasons.

Leading clinical centers have already trusted their patient data with us and we are negotiating pilots with more than 20 partners around the world.


Founders

Dora
Sabino

CEO, Blazar

Experience in cancer research, led projects in industry-modelling cancer treatment response

Renan
Pereira

CTO, Blazar

Data scientist, experience developing and managing scalable machine learning models

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.